What an IBAT inhibitor, a successful Phase III program, and...
Read MoreFrom Claudia's Desk
Where biopharma strategy meets science. I write about AI in drug discovery, BD deal-making, and the harder questions behind the headlines — for VCs, founders, and operators navigating where biotech goes next.
Read the latest below
AI Won Round One. The Hardest Problem Is Still Ahead
How systems biology and network medicine may help solve the...
Read More
Don't miss the Next Post
Join readers in biotech venture, pharma BD, and drug discovery strategy who get my take first.